secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seaport Therapeutics, Inc. (SPTX)
CIK:        0002042347
Form:       8-K
Filed at:   2026-05-04T23:59:59+00:00
Accession:  0001193125-26-204086
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Seaport Therapeutics adopts new charter authorizing 700M shares, completes IPO
------------------------------------------------------------------------------

- Filed amended charter authorizing 700M total shares: 500M voting common, 200M non-voting common, 10M undesignated preferred.
- Eliminated references to prior preferred stock series; Board may issue undesignated preferred in series.
- Adopted amended bylaws with stockholder meeting procedures, advance notice proposals, and director nomination rules.
- Charter and bylaw changes became effective upon IPO consummation on May 4, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2042347/000119312526204086/0001193125-26-204086-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2042347/000119312526204086/d150068d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-204086

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer